Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutamate dehydrogenase 1 pseudogene 9 (GLUD1P9) is a nonfunctional genomic DNA sequence in humans that bears high sequence similarity to the protein-coding glutamate dehydrogenase 1 (GLUD1) gene but has lost coding or regulatory potential due to disabling mutations or loss of regulatory sequences. As a pseudogene, GLUD1P9 does not encode an active protein or RNA product and does not participate directly in cellular metabolism, signaling, or disease processes. Its presence is essentially a molecular fossil in the human genome, with no known physiological or pathological roles[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamate dehydrogenase 1 pseudogene 9 (GLUD1P9).